Compound ID | 2823
Class: Antibiofilm agent
| Agent Type: | Synthetic; Small molecule; Indirect acting; Antibiofilm; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Prevents initial adhesion and production of polysaccharide intercellular adhesin required for biofilm formation |
| Target Pathogen: | Active against Staphylococcus aureus |
| Description: | Synthetic compound; small molecule with indolylmaleimide core; shows no antibacterial activity but inhibits biofilm formation |
| Institute where first reported: | Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China |
| Year first mentioned: | 2023 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/spectrum.01596-23 |